Analyst Recommendations

BMO Capital analyst issues OUTPERFORM recommendation for ECL on October 30, 2025 01:55PM ET. The previous analyst recommendation was Outperform.ECL was trading at $261.32 at issue of the...

October 30, 2025   ECL 0.52%

BMO Capital analyst issues MARKET PERFORM recommendation for EQIX on October 30, 2025 01:50PM ET. The previous analyst recommendation was Market Perform.EQIX was trading at $844.72 at issue...

October 30, 2025   EQIX -0.63%

RBC Capital analyst issues SECTOR PERFORM recommendation for NBR on October 30, 2025 01:47PM ET. The previous analyst recommendation was Sector Perform.NBR was trading at $52.13 at issue...

October 30, 2025   NBR -3.50%

RBC Capital analyst issues SECTOR PERFORM recommendation for REYN on October 30, 2025 01:46PM ET. The previous analyst recommendation was Sector Perform.REYN was trading at $25.6804 at issue...

October 30, 2025   REYN -0.60%

RBC Capital analyst issues SECTOR PERFORM recommendation for IVZ on October 30, 2025 01:51PM ET. The previous analyst recommendation was Sector Perform.IVZ was trading at $23.945 at issue...

October 30, 2025   IVZ -0.35%

Scotiabank analyst issues SECTOR PERFORM recommendation for VZ on October 30, 2025 02:03PM ET. The previous analyst recommendation was Sector Perform.VZ was trading at $39.355 at issue of...

October 30, 2025   VZ -0.35%

Cowen & Co. analyst issues HOLD recommendation for ADP on October 30, 2025 02:43PM ET. The previous analyst recommendation was Hold.ADP was trading at $263.5925 at issue of...

October 30, 2025   ADP -0.07%

Benchmark analyst issues BUY recommendation for CHRW on October 30, 2025 02:33PM ET. The previous analyst recommendation was Buy.CHRW was trading at $155.425 at issue of the analyst...

October 30, 2025   CHRW -0.12%

RBC Capital analyst issues OUTPERFORM recommendation for CVS on October 30, 2025 02:13PM ET. The previous analyst recommendation was Outperform.CVS was trading at $76.68 at issue of the...

October 30, 2025   CVS -0.92%

Tigress Financial analyst issues BUY recommendation for MBLY on October 30, 2025 02:25PM ET. The previous analyst recommendation was Buy.MBLY was trading at $13.0643 at issue of the...

October 30, 2025   MBLY -0.51%